Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesUnited-Guardian Inc

United-Guardian Inc

Consumer Defensive Household & Personal Products
PortfolioPortfolio WatchlistWatchlist
Company price
8.705 USD -0.46 ( 4.97%)
Last update at 2026-11-11T21:00:00Z
VOLUME
53786
Market Cap
32.80M
P/E
13.47

Momentum Score

…

United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil incorporates into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
8.40
Low
9.30
High
52 Week Price Range
5.19
Low
8.14
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
9.16
Dividend Yield
5.59%
Revenue TTM
11.21M
Revenue Per Share
2.44
Gross Profit TTM
5.26M
Debt / Equity
-
ROE
21.35%
Net Debt
-1.25M
ROCE
23.10%
Diluted EPS TTM
0.53

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 2.64M 4.11M 3.25M 3.23M 5.88M
Net income 2.11M 3.25M 2.58M 2.57M 4.66M
Gross profit 5.03M 6.46M 5.41M 6.70M 8.18M
Reconciled depreciation 0.11M 0.10M 0.11M 0.14M 0.15M
Ebit 2.64M 4.11M 3.25M 4.04M 5.67M
Ebitda 2.75M 4.20M 3.36M 4.85M 5.46M
Depreciation and amortization 0.11M 0.10M 0.11M 0.81M -0.21M
Operating income 2.24M 3.65M 2.86M 4.04M 5.67M
Other operating expenses 8.30M 8.54M 8.02M 8.66M 8.26M
Interest expense - - - 1.62M 0.57M
Tax provision 0.54M 0.86M 0.64M 0.66M 1.22M
Income tax expense 0.54M 0.86M 0.67M 0.66M 1.22M
Total revenue 10.55M 12.18M 10.89M 12.70M 13.93M
Total operating expenses 2.79M 2.81M 2.54M 2.66M 2.51M
Cost of revenue 5.51M 5.72M 5.48M 6.00M 5.75M
Total other income expense net 0.40M 0.46M 0.39M -0.81M 0.21M
Net income from continuing ops 2.11M 3.25M 2.52M 2.57M 4.66M
Net income applicable to common shares - - - 2.57M 4.66M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 13.11M 13.80M 13.36M 10.64M 12.24M
Other current assets 0.53M 0.39M 0.37M 0.20M 0.19M
Total liab 1.88M 1.91M 1.97M 1.37M 2.42M
Total stockholder equity 11.23M 11.88M 11.39M 9.27M 9.82M
Other current liab 1.18M 1.49M 1.36M 1.34M 1.74M
Common stock 0.46M 0.46M 0.46M 0.46M 0.46M
Capital stock 0.46M 0.46M 0.46M 0.46M 0.46M
Retained earnings 10.77M 11.42M 10.93M 8.81M 9.36M
Other liab - - - - 0.08M
Other assets - - 0.00M 0.11M -
Cash 1.25M 1.88M 8.24M 0.83M 0.53M
Total current liabilities 1.67M 1.91M 1.53M 1.37M 2.34M
Current deferred revenue 0.01M - 0.02M - 0.19M
Net debt -1.25M -1.88M -8.24M -0.83M -0.53M
Short term debt - - 0.02M - -
Other stockholder equity - - - - 9.82M
Property plant equipment - - - 0.56M 0.66M
Total current assets 12.20M 12.67M 12.25M 9.97M 11.58M
Net tangible assets - - - 9.27M 9.82M
Short term investments 7.32M 7.52M 0.85M 5.65M 7.64M
Net receivables 1.59M 1.43M 1.57M 1.43M 1.81M
Inventory 1.51M 1.45M 1.22M 1.67M 1.41M
Accounts payable 0.48M 0.43M 0.13M 0.03M 0.41M
Non currrent assets other - -7.19M -0.00M - -0.08M
Non current assets total 0.91M 1.13M 1.11M 0.67M 0.66M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.23M -7.08M 5.86M 0.90M -0.07M
Change to liabilities - - - -0.57M 0.57M
Total cashflows from investing activities 0.18M -7.08M 4.73M 0.90M -0.18M
Total cash from financing activities -2.77M -2.76M -0.46M -3.12M -5.19M
Change to operating activities - - - -0.31M 0.23M
Net income 2.11M 3.25M 2.58M 2.57M 4.66M
Change in cash -0.62M -6.37M 7.41M 0.30M -0.06M
Begin period cash flow 1.88M 8.24M 0.83M 0.53M 0.59M
End period cash flow 1.25M 1.88M 8.24M 0.83M 0.53M
Total cash from operating activities 1.97M 3.47M 3.14M 2.53M 5.31M
Depreciation 0.11M 0.10M 0.11M 0.14M 0.15M
Other cashflows from investing activities -0.06M -0.43M 0.01M - -
Dividends paid 2.77M 2.76M 0.46M -3.12M -5.19M
Change to inventory -0.05M -0.21M 0.47M -0.29M 0.00M
Change to account receivables -0.16M 0.14M -0.14M 0.39M -0.43M
Other cashflows from financing activities - - 4.73M 0.90M -0.18M
Change to netincome - - - 0.88M -0.05M
Capital expenditures 0.06M 0.43M 0.17M 0.08M 0.12M
Change in working capital -0.60M 0.29M 0.51M -1.06M 0.56M
Stock based compensation - - 0.05M - -
Other non cash items -0.03M -0.04M -0.11M 1.08M 0.01M
Free cash flow 1.91M 3.03M 2.98M 2.45M 5.20M

Peer Comparison*

Sector: Consumer Defensive Industry: Household & Personal Products

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
UG
United-Guardian Inc		 -0.46
4.97%		 8.71 13.47 26.53 2.93 2.83 2.08 9.51
PG
Procter & Gamble Company		 -0.99
0.59%		 167.67 23.58 22.62 4.07 7.24 4.40 16.08
LRLCF
L'Oréal S.A		 -
-%		 497.60 41.14 34.25 6.52 8.59 6.67 27.76
LRLCY
L’Oreal Co ADR		 -0.27
0.27%		 99.39 32.44 25.64 5.16 6.03 4.79 19.51
UL
Unilever PLC ADR		 -0.69
1.04%		 65.78 21.53 16.39 2.66 7.29 2.77 12.45

Profile*

United-Guardian Inc

United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil incorporates into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

230 Marcus Boulevard, Hauppauge, NY, United States, 11788

631 273 0900

https://u-g.com

23

Name Title Year Born
Ms. Donna Vigilante VP, R&D Mang. and Director of Technical Services 1980
Mr. Peter A. Hiltunen Sr. VP & Production Mang. 1959
Ms. Beatriz Blanco CEO, Pres & Director NA
Ms. Andrea J. Young CFO, Treasurer, Controller, Sec. & HR Mang. 1969
Ms. Donna Vigilante President 1981
Ms. Andrea J. Young CFO, Treasurer, Controller, Secretary & Human Resources Manager 1969
Mr. Peter A. Hiltunen Senior VP of Production & Procurement and Production Manager 1959
Ms. Donna Vigilante President & Director 1981
Ms. Denise Costrini Marketing Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…